Category: Commercial Operations

Pharmaceutical executives are navigating through an increasingly complex regulatory landscape due to the Inflation Reduction Act (IRA).  It introduced substantial drug cost shifting and now impacts strategic and analytical planning for insurance carriers and drug manufacturers alike. This pivotal legislation brings transparency, and Medicare negotiation to drug pricing, through measures like the 2024 Catastrophic Coverage […]

ARLINGTON – CareSet released the updated DocGraph HOP Teaming Dataset during the 2022 Health Datapalooza and National Health Policy Conference. The release offers the most detailed and up-to-date picture of patient-sharing relationships between all Medicare providers in the US healthcare system. This public use file provides some of the most timely and necessary insights into […]

Picture the following scenario: A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these […]

In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself. CareSet’s Part D Targeting product provides brand teams clarity using Medicare’s unblocked claims data. This allows us to […]

New Medicare Part D Targeting subscription datasets offer census level accuracy.New Part D Targeting subscription datasets are now available from CareSet to aid pharma marketing decisions.  These datasets supercharge patient’s access to specialty treatments by revealing data that is blocked in commercial datasets.  CareSet receives Part D data two weeks after Medicare approves the data […]

While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand. Publicly available datasets, as well as commercially available datasets, are all over the internet. […]

2019 was CareSet’s third attendance at the annual meeting held in San Diego. At our fist PMSA, we were two people with a lot of heart and a lot of ground to cover. This year, with a growing team and a growing reputation, it made sense to show up in full force. Co-founder and CTO, […]

CareSet made a big splash at SXSW 2018, hosting Put Down the Scalpel: Non-Invasive Heart Solutions on March 10th at the Austin Convention Center. The session had an all-star cast of subject matter experts, including panelists Patrick Wayte, Senior Vice President, Center for Health Technology and Innovations for The American Heart Association, Cat Oyler, Global […]

Amongst the improved programming of SXSW healthcare, CareSet’s SXSW panel is sandwiched between AHA and Merck events.  The infamous Fred Trotter moderates a discussion about new school cardiovascular care lead by four executive experts.  We are all affected and will be there. Date: March 10th, 2018Time: 11:00AM Duration: 60 minutes  Venue: Austin Convention Center Room: […]

CareSet and it’s co-founders have a history of advocacy and thought leadership around data security, “hactivism,” and data journalism. Below is a collection of some of our favorite attributions.I. CareSet in the News https://www.xconomy.com/texas/2017/03/06/%E2%80%8Bex-vice-president-biden-to-speak-about-cancer-moonshot-at-sxsw/Shah, A. (2017, March 6). Ex-Vice President Biden to speak about Cancer Moonshot at SXSW. Retrieved from https://www.xconomy.com/texas/2017/03/06/%E2%80%8Bex-vice-president-biden-to-speak-about-cancer-moonshot-at-sxsw/ https://www.forbes.com/sites/oreillymedia/2014/04/13/leading-by-example-two-stories/#2bf490c4280cO’Reilly, T. (2014, April […]